An RCSI and Children's Health Ireland study has shown that Ivacaftor is safe for treating newborns with cystic fibrosis from four weeks old.
Silicon Republic 2:15 pm on April 11, 2024
https://www.siliconrepublic.com/innovation/cystic-fibrosis-treatment-rcsi-study-ivacaftor
1996-2024 all rights reserved. Privacy Policy. All trademarks and copyrights held by respective owners. |